Retraction
Functional characterization of the nitrogen permease regulator-like-2 candidate tumor suppressor gene in colorectal cancer cell lines
Paper Information
Record ID:
47509
Author(s):
Journal:
Publication Date:
June 03, 2015
Retraction Date:
September 11, 2023
(2.2 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/mmr.2023.13088Additional Notes:
See also: https://pubpeer.com/publications/B1E0BCC80AB9DA3C19E117FEEA2D7E
Citations (13)
13
Total Citations9
Post-Retraction(69.2%)
4
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
8
Within 1 year
0
After 2+ years
512
Days since retraction (latest)
NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song et al. (9 authors)
eLife
Open Access
Published: Feb 2025
1 citation
1 citation
512 days after retraction
Reviewer #1 (Public Review): NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Unknown Authors
Unknown Journal
Open Access
Published: Jul 2024
302 days after retraction
Reviewer #2 (Public Review): NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Unknown Authors
Unknown Journal
Open Access
Published: Jul 2024
302 days after retraction
eLife assessment: NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Jia Wei
Unknown Journal
Open Access
Published: Jul 2024
302 days after retraction
Author response: NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song et al. (9 authors)
Unknown Journal
Open Access
Published: Jul 2024
302 days after retraction
NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song et al. (9 authors)
Unknown Journal
Open Access
Published: Jul 2024
302 days after retraction
NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song et al. (9 authors)
eLife
Open Access
Published: Jul 2024
302 days after retraction
Reviewer #3 (Public Review): NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Unknown Authors
Unknown Journal
Open Access
Published: Jul 2024
302 days after retraction
NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song et al. (9 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2024
199 days after retraction
<p>Nitrogen Permease Regulator-Like-2 Exhibited Anti-Tumor Effects And Enhanced The Sensitivity Of Colorectal Cancer Cells To Oxaliplatin And 5-Fluorouracil</p>
Aiyun Liu, Jiutao Qiao, Li-Yuan He et al. (7 authors)
OncoTargets and Therapy
Open Access
Published: Oct 2019
8 citations
8 citations
1441 days before retraction
Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway
Shasha Liu, Bingrong Liu
Medical Science Monitor
Open Access
Published: Mar 2018
6 citations
6 citations
2012 days before retraction
Tumor suppressor NPRL2 induces ROS production and DNA damage response
Yinxing Ma, Licia Silveri, John LaCava et al. (4 authors)
Scientific Reports
Open Access
Published: Nov 2017
29 citations
29 citations
2135 days before retraction
Biological characteristics of renal cancer cells after CTP-mediated cancer suppressor gene NPRL2 protein treatment
Yang Zeng, Xiaobo Shi, Zhengyong Yuan et al. (8 authors)
Biological Chemistry
Published: May 2016
4 citations
4 citations
2674 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025